Today: 18 November 2025
Subscribe
Browse Category

Mergers & Acquisitions News 22 October 2025 - 28 October 2025

Cygnet’s $1.4 B Oil Patch Power Play – Kiwetinohk Shareholders Score Big Premium in Alberta Energy Deal

Cygnet’s $1.4 B Oil Patch Power Play – Kiwetinohk Shareholders Score Big Premium in Alberta Energy Deal

Deal Overview & Terms In a significant shake-up for the Canadian oil and gas sector, Cygnet Energy – a privately held exploration and production company – has agreed to buy publicly traded Kiwetinohk Energy Corp. in an all-cash acquisition. Announced on October 28, 2025, the definitive arrangement agreement will see Cygnet pay C$24.75 per share for all Kiwetinohk common shares reuters.com reuters.com. This values the transaction at approximately C$1.4 billion (including debt), just shy of US$1 billion. The takeover will be executed via a court-approved Plan of Arrangement under Canadian law and is expected to close by late December 2025, assuming regulatory
28 October 2025
 ·  ·  ·  · 
Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

October 27, 2025: Huntington Bancshares Incorporated (NASDAQ: HBAN) is making headlines with a potent mix of robust earnings and aggressive expansion. The Columbus, Ohio-based regional bank is riding high on better-than-expected Q3 results and announcing a $7.4 billion takeover of Cadence Bank, a bold merger that extends Huntington’s footprint into the lucrative Texas and Southeast markets. Investors are parsing what these developments mean for HBAN’s stock price and future. Stock Price and Recent Trading Action As of October 27, Huntington’s stock is hovering near $15.5 per share in afternoon trading. That price is down a few percent from Friday’s close,
27 October 2025
 ·  ·  ·  ·  · 
American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

American Water & Essential Utilities to Merge in $63B ‘Mega-Deal’ – What Investors Need to Know

In-Depth Report: On Oct. 26, 2025, American Water Works Co. (AWK) and Essential Utilities, Inc. (WTRG) surprised the utilities sector by announcing a definitive all-stock merger agreement businesswire.com investing.com. The companies said the combination creates the largest regulated water/wastewater utility in the U.S., serving roughly 14 million people in 14 states ts2.tech. According to the companies, shareholders of each firm unanimously approved the deal, which carries a pro forma market value of about $40 billion (about $63 billion including debt) marketscreener.com nasdaq.com. American Water shareholders will receive 0.305 shares for each Essential share, equating to a ~10% premium to WTRG’s recent trading
27 October 2025
 ·  ·  ·  ·  ·  · 
Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Deal Details and Rationale On Oct. 27, Huntington Bancshares announced it will absorb Cadence Bank in a stock-for-stock merger finimize.com sec.gov. Cadence is a $53 billion-asset regional bank based in Houston/Tupelo, with 390 branches in eight states sec.gov bankingdive.com. Under the deal Huntington will issue 2.475 of its shares per Cadence share. Based on HBAN’s Oct. 24 close of $16.07, the exchange price equals $39.77 per Cadence share (a ~9% premium) finimize.com bankingdive.com. This values Cadence at $7.4 billion in total finimize.com bankingdive.com. The combined bank will have about $276 billion in assets, $220 billion in deposits, and $184 billion in loans and leases reuters.com bankingdive.com.
27 October 2025
 ·  ·  ·  ·  ·  · 
RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

Stock Performance & Recent Trends Prior to the buyout news, RNA stock had been on a steady uptrend in 2025. The share price more than doubled from the low-$20s a year ago to the high-$40s this month ts2.tech. In the past three months alone, RNA jumped ~40%, fueled by upbeat clinical updates and M&A speculation ts2.tech. The stock hit a 52-week peak of $56 in early October ts2.tech after its lead DMD therapy showed strong results and secured FDA Breakthrough designation. Shares pulled back slightly to around $49 by late October, but remained up 100%+ year-over-year ts2.tech. A major catalyst
27 October 2025
 ·  ·  ·  ·  ·  · 
Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Bottom Line: Avidity Biosciences’ stock is set to explode higher on Novartis’s $12 billion buyout, capping off a dramatic run fueled by breakthrough science and takeover buzz. The high-premium deal underscores the massive value of RNA therapeutics for rare diseases – and signals that big pharma’s biotech spending spree isn’t slowing down. While Avidity’s chapter as an independent company is closing, its novel treatments may reach patients faster under Novartis’s umbrella. Investors now await the finalization of the deal (and SpinCo details), as Wall Street cheers another biotech success story in the making. 🏥💥 Sources: reuters.com reuters.com business-standard.com biospace.com biospace.com
26 October 2025
 ·  ·  ·  · 
DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

Record Revenue, Rising Margins Drive Optimism In early August, DraftKings reported blowout Q2 results – revenue of $1.51 billion (up 37% YoY) and adjusted EBITDA of $301 million, more than double the prior record investing.com. Management noted strong sportsbook hold and growth in monthly active users. CEO Jason Robins said, “We set records for revenue, net income and Adjusted EBITDA in the second quarter” investing.com. The company reaffirmed its full-year outlook, expecting to hit the high end of $6.2–6.4B revenue and roughly $850M EBITDA investing.com. The upbeat results lifted DraftKings shares (they rose ~4% immediately after release investing.com) and helped narrow the
25 October 2025
 ·  ·  ·  · 
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar Stock Skyrockets 31% on Buyout Buzz – Lidar Boom Back in Spotlight?

Luminar’s LiDAR technology has gained attention as its stock popped in late October 2025. Investors are weighing the firm’s strong auto partnerships against its slim revenue base and recent buyout proposal. Stock Rally and Buyout Speculation Luminar Technologies, a Florida-based maker of long-range automotive LiDAR, has suddenly found itself in the headlines. On Oct. 25, 2025, Luminar’s stock jumped about 31% to roughly $2.22 reuters.com. This surge came amid two key catalysts: a broad tech stock rally and speculation around founder Austin Russell’s plans. According to an SEC filing and media reports, Russell – who was ousted as CEO in
25 October 2025
 ·  ·  ·  ·  · 
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr (GRND) Stock Explodes on $18 Buyout Buzz – Is a $3.5B Takeover Coming?

Stock Reaction and Trading Activity On Friday Oct 24, GRND shot up from the low-$12 range into the mid-$15s. Finviz data show Friday’s prevailing price was $12.67 with the stock closing at $15.06 (a +18.86% jump) finviz.com. Investing.com and TechStock² report intraday spikes to ~$16 (after the $18 bid was revealed) before settling near $15 ts2.tech investing.com. Trading volume was ~11.4 M shares on Friday – roughly five times the 6-week average – reflecting the frenzied demand finviz.com. In short, the buyout news sent GRND soaring. By contrast, peers like Bumble and Match saw only modest moves. (Note: U.S. markets were closed
25 October 2025
 ·  ·  ·  ·  · 
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Buyout Buzz Sends GRND Soaring Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s close investing.com. The rally came after Grindr confirmed that its two largest shareholders – board Chair James Fu Bin Lu and director G. Raymond Zage III – had submitted a preliminary proposal to take the company private at $18.00 per share in cash d18rn0p25nwr6d.cloudfront.net d18rn0p25nwr6d.cloudfront.net. By the end of the day, Grindr stock was hovering around $15.90 (up ~25.6%) on
24 October 2025
 ·  ·  ·  ·  · 
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Stock Price Rallies Amid Mortgage Market Shifts Rocket Companies’ stock has been on a wild ride this year. As of Oct. 24, RKT was trading around $16.94-$17 per share google.com – roughly flat on the day after some early swings (intraday high ~$17.10, low ~$16.41) google.com. That price is about 70-80% higher than where it started 2025, making Rocket a standout gainer in an otherwise sluggish housing sector youtube.com. The stock reached as high as the low-$20s in early October, when excitement over Rocket’s latest acquisition peaked, before cooling off. In fact, RKT shares have climbed about 54% since late
24 October 2025
 ·  ·  ·  · 
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes Buyout Sparks Rally in AVDL Stock On Oct. 22, 2025, Alkermes announced it would acquire Avadel for $18.50 cash per share plus a $1.50 contingent value right (CVR) tied to an FDA approval for idiopathic hypersomnia, valuing the deal at up to $2.1 billion prnewswire.com. The all-cash offer represents roughly a 12% premium to Avadel’s recent trading range. Avadel CEO Greg Divis hailed the terms as “a compelling outcome for our shareholders” prnewswire.com, while Alkermes CEO Richard Pops said the deal is “a pivotal step” to accelerate Alkermes’ entry into the sleep-medicine market prnewswire.com. Avadel’s board and Alkermes’ board have
22 October 2025
 ·  ·  ·  ·  ·  ·  · 
1 … 5 6 7 8 9 … 12
Go toTop